Gilead Sciences, Inc. (OQ:GILD)

Business Focus: Bio Therapeutic Drugs

Recent Price for GILD
USD 69.254 -0.036 (-0.052%)
NSQ Delayed 15 minutes
10:07 EST
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
69.730 103.100 6.97 1,239,857 91,553.79
1-Day Low 52-Week Low Yield Avg. Volume  
69.020 65.380 3.0% 13,193,909  

Latest 10 SEC filings (by transaction date) for GILD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Feb 21/17 Feb 16/17 Washington Robin L Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -7,814 $70.31
Feb 21/17 Feb 16/17 Washington Robin L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,185  
Feb 21/17 Feb 16/17 Washington Robin L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,516  
Feb 21/17 Feb 16/17 Milligan John F Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -8,389 $70.31
Feb 21/17 Feb 16/17 Milligan John F Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,429  
Feb 21/17 Feb 16/17 Milligan John F Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,606  
Feb 21/17 Feb 16/17 Meyers James R Indirect Ownership Common Stock G - Gift 4,354  
Feb 21/17 Feb 16/17 Meyers James R Direct Ownership Common Stock G - Gift -4,354  
Feb 21/17 Feb 16/17 Meyers James R Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,053 $70.31
Feb 21/17 Feb 16/17 Meyers James R Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,022  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for GILD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Feb 21/17 Feb 16/17 Washington Robin L Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -7,814 $70.31
Feb 21/17 Feb 16/17 Washington Robin L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,185  
Feb 21/17 Feb 16/17 Washington Robin L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,516  
Feb 21/17 Feb 15/17 Washington Robin L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 315 $59.33
Feb 21/17 Feb 16/17 Milligan John F Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -8,389 $70.31
Feb 21/17 Feb 16/17 Milligan John F Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,429  
Feb 21/17 Feb 16/17 Milligan John F Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,606  
Feb 21/17 Feb 15/17 Milligan John F Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 315 $59.33
Feb 21/17 Feb 16/17 Meyers James R Indirect Ownership Common Stock G - Gift 4,354  
Feb 21/17 Feb 16/17 Meyers James R Direct Ownership Common Stock G - Gift -4,354  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Share an Idea with Easy Blurb
140

Twitter

Search (past week) for $GILD

StockTwits